Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad and PharmaMar Announce First Commercial Partnership With Myriad's New HRD Test

SALT LAKE CITY, March 26, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has signed an agreement with PharmaMar, a leader in the development of marine-derived...
March 06, 2013 07:00 ET | Source: Myriad Genetics, Inc.

BRCA Testing Granted Preventive Care Designation Under the Affordable Care Act

SALT LAKE CITY, March 6, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that three federal agencies including the U.S. Department of Health and Human Services, the U.S....
March 05, 2013 07:00 ET | Source: Myriad Genetics, Inc.

Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study

SALT LAKE CITY, March 5, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in the Journal of Clinical Oncology demonstrated that its Prolaris test,...
March 01, 2013 20:00 ET | Source: Myriad Genetics, Inc.

Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance for Fiscal 2013

SALT LAKE CITY, March 1, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Noridian Administrative Services LLC ("Noridian"), Medicare administrative contractor for...
February 05, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Second Quarter Fiscal Year 2013 Results

SALT LAKE CITY, Feb. 5, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its second fiscal quarter ended December 31, 2012. Revenue for the second fiscal...
January 15, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013

SALT LAKE CITY, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the second fiscal quarter 2013 following the close of...
December 17, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference

SALT LAKE CITY, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 2013 J.P. Morgan Annual...
December 10, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Announces Diabetes Collaboration With Sanofi

SALT LAKE CITY, Dec. 10, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq:MYGN) announced today that Myriad RBM, a wholly owned subsidiary of Myriad Genetics, has entered into a research collaboration...
December 07, 2012 18:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer

SALT LAKE CITY, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled "Homologous recombination deficiency (HRD) score predicts pathologic...
November 30, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Supreme Court of the United States to Hear Isolated DNA Patent Case

SALT LAKE CITY, Nov. 30, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) reported today that the Supreme Court of the United States granted certiorari agreeing to hear the case of The...